nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Parkinson's disease	0.397	0.577	CbGaD
Fingolimod—CYP2D6—Parkinson's disease	0.291	0.423	CbGaD
Fingolimod—CYP4F2—tongue—Parkinson's disease	0.0123	0.12	CbGeAlD
Fingolimod—S1PR1—brainstem—Parkinson's disease	0.00421	0.0412	CbGeAlD
Fingolimod—S1PR1—forebrain—Parkinson's disease	0.00406	0.0398	CbGeAlD
Fingolimod—S1PR3—cardiovascular system—Parkinson's disease	0.0039	0.0381	CbGeAlD
Fingolimod—S1PR5—midbrain—Parkinson's disease	0.00366	0.0358	CbGeAlD
Fingolimod—S1PR1—cardiovascular system—Parkinson's disease	0.00343	0.0336	CbGeAlD
Fingolimod—SPHK1—cardiovascular system—Parkinson's disease	0.0034	0.0333	CbGeAlD
Fingolimod—S1PR5—head—Parkinson's disease	0.00317	0.0311	CbGeAlD
Fingolimod—S1PR5—nervous system—Parkinson's disease	0.00301	0.0295	CbGeAlD
Fingolimod—CYP4F2—head—Parkinson's disease	0.00297	0.0291	CbGeAlD
Fingolimod—S1PR5—central nervous system—Parkinson's disease	0.0029	0.0284	CbGeAlD
Fingolimod—S1PR5—cerebellum—Parkinson's disease	0.00283	0.0277	CbGeAlD
Fingolimod—CYP4F12—medulla oblongata—Parkinson's disease	0.00279	0.0273	CbGeAlD
Fingolimod—S1PR1—midbrain—Parkinson's disease	0.00268	0.0263	CbGeAlD
Fingolimod—SPHK1—midbrain—Parkinson's disease	0.00265	0.026	CbGeAlD
Fingolimod—S1PR3—head—Parkinson's disease	0.00264	0.0258	CbGeAlD
Fingolimod—S1PR1—spinal cord—Parkinson's disease	0.00262	0.0256	CbGeAlD
Fingolimod—CYP4F12—midbrain—Parkinson's disease	0.00255	0.025	CbGeAlD
Fingolimod—S1PR3—nervous system—Parkinson's disease	0.0025	0.0245	CbGeAlD
Fingolimod—CYP4F12—spinal cord—Parkinson's disease	0.00249	0.0244	CbGeAlD
Fingolimod—S1PR3—central nervous system—Parkinson's disease	0.00241	0.0236	CbGeAlD
Fingolimod—S1PR1—head—Parkinson's disease	0.00233	0.0228	CbGeAlD
Fingolimod—S1PR5—brain—Parkinson's disease	0.0023	0.0225	CbGeAlD
Fingolimod—S1PR1—nervous system—Parkinson's disease	0.0022	0.0216	CbGeAlD
Fingolimod—SPHK1—nervous system—Parkinson's disease	0.00218	0.0214	CbGeAlD
Fingolimod—S1PR1—central nervous system—Parkinson's disease	0.00212	0.0208	CbGeAlD
Fingolimod—S1PR1—cerebellum—Parkinson's disease	0.00207	0.0203	CbGeAlD
Fingolimod—CYP4F12—cerebellum—Parkinson's disease	0.00197	0.0193	CbGeAlD
Fingolimod—S1PR3—brain—Parkinson's disease	0.00191	0.0187	CbGeAlD
Fingolimod—S1PR1—brain—Parkinson's disease	0.00169	0.0165	CbGeAlD
Fingolimod—SPHK1—brain—Parkinson's disease	0.00167	0.0163	CbGeAlD
Fingolimod—CYP4F12—brain—Parkinson's disease	0.0016	0.0157	CbGeAlD
Fingolimod—CYP2D6—hindbrain—Parkinson's disease	0.000932	0.00912	CbGeAlD
Fingolimod—CYP2E1—cardiovascular system—Parkinson's disease	0.000551	0.00539	CbGeAlD
Fingolimod—CYP2D6—brainstem—Parkinson's disease	0.000534	0.00523	CbGeAlD
Fingolimod—CYP2D6—forebrain—Parkinson's disease	0.000516	0.00505	CbGeAlD
Fingolimod—CYP2E1—medulla oblongata—Parkinson's disease	0.00047	0.00461	CbGeAlD
Fingolimod—CYP2E1—spinal cord—Parkinson's disease	0.000419	0.00411	CbGeAlD
Fingolimod—CYP2E1—head—Parkinson's disease	0.000373	0.00365	CbGeAlD
Fingolimod—CYP2E1—nervous system—Parkinson's disease	0.000353	0.00346	CbGeAlD
Fingolimod—CYP2E1—central nervous system—Parkinson's disease	0.00034	0.00333	CbGeAlD
Fingolimod—CYP2E1—cerebellum—Parkinson's disease	0.000333	0.00326	CbGeAlD
Fingolimod—CYP2D6—head—Parkinson's disease	0.000295	0.00289	CbGeAlD
Fingolimod—CYP3A4—nervous system—Parkinson's disease	0.000284	0.00278	CbGeAlD
Fingolimod—CYP2D6—nervous system—Parkinson's disease	0.00028	0.00274	CbGeAlD
Fingolimod—CYP3A4—central nervous system—Parkinson's disease	0.000274	0.00268	CbGeAlD
Fingolimod—CYP2E1—brain—Parkinson's disease	0.00027	0.00265	CbGeAlD
Fingolimod—CYP2D6—central nervous system—Parkinson's disease	0.000269	0.00264	CbGeAlD
Fingolimod—CYP2D6—cerebellum—Parkinson's disease	0.000263	0.00258	CbGeAlD
Fingolimod—CYP2D6—brain—Parkinson's disease	0.000214	0.00209	CbGeAlD
Fingolimod—SPHK1—Signaling Pathways—FGF20—Parkinson's disease	9.05e-05	0.000431	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	9.04e-05	0.000431	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—COMT—Parkinson's disease	8.98e-05	0.000428	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	8.97e-05	0.000427	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTP1—Parkinson's disease	8.94e-05	0.000426	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MAOA—Parkinson's disease	8.92e-05	0.000425	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	8.92e-05	0.000425	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD3—Parkinson's disease	8.86e-05	0.000422	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD3—Parkinson's disease	8.86e-05	0.000422	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—HMOX1—Parkinson's disease	8.82e-05	0.00042	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP2D6—Parkinson's disease	8.79e-05	0.000419	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADORA2A—Parkinson's disease	8.77e-05	0.000418	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CYCS—Parkinson's disease	8.76e-05	0.000417	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGB—Parkinson's disease	8.65e-05	0.000412	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CTGF—Parkinson's disease	8.63e-05	0.000411	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR2A—Parkinson's disease	8.63e-05	0.000411	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR1A—Parkinson's disease	8.6e-05	0.00041	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADRBK1—Parkinson's disease	8.59e-05	0.000409	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.48e-05	0.000404	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TAC1—Parkinson's disease	8.47e-05	0.000404	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ABCB1—Parkinson's disease	8.46e-05	0.000403	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	8.44e-05	0.000402	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.32e-05	0.000397	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR7—Parkinson's disease	8.32e-05	0.000397	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD2—Parkinson's disease	8.32e-05	0.000397	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	8.32e-05	0.000396	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—INS—Parkinson's disease	8.31e-05	0.000396	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD1—Parkinson's disease	8.31e-05	0.000396	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRBK1—Parkinson's disease	8.27e-05	0.000394	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRBK1—Parkinson's disease	8.27e-05	0.000394	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTM1—Parkinson's disease	8.22e-05	0.000391	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	8.21e-05	0.000391	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—INSR—Parkinson's disease	8.1e-05	0.000386	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	8.06e-05	0.000384	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD3—Parkinson's disease	8.04e-05	0.000383	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP2E1—Parkinson's disease	8.04e-05	0.000383	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR7—Parkinson's disease	8.01e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD2—Parkinson's disease	8.01e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR7—Parkinson's disease	8.01e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD2—Parkinson's disease	8.01e-05	0.000382	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NQO1—Parkinson's disease	7.95e-05	0.000379	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GPX1—Parkinson's disease	7.87e-05	0.000375	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TH—Parkinson's disease	7.84e-05	0.000373	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—COMT—Parkinson's disease	7.76e-05	0.000369	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTP1—Parkinson's disease	7.72e-05	0.000368	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MAOA—Parkinson's disease	7.7e-05	0.000367	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGB—Parkinson's disease	7.65e-05	0.000365	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—HMOX1—Parkinson's disease	7.61e-05	0.000363	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR1A—Parkinson's disease	7.61e-05	0.000363	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYCS—Parkinson's disease	7.52e-05	0.000358	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRBK1—Parkinson's disease	7.51e-05	0.000358	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TAC1—Parkinson's disease	7.5e-05	0.000357	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	7.37e-05	0.000351	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD1—Parkinson's disease	7.35e-05	0.00035	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCB1—Parkinson's disease	7.31e-05	0.000348	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR7—Parkinson's disease	7.28e-05	0.000347	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD2—Parkinson's disease	7.28e-05	0.000347	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MTHFR—Parkinson's disease	7.26e-05	0.000346	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD3—Parkinson's disease	7.12e-05	0.000339	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTM1—Parkinson's disease	7.09e-05	0.000338	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF2—Parkinson's disease	6.98e-05	0.000332	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GPX1—Parkinson's disease	6.79e-05	0.000324	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—APOE—Parkinson's disease	6.76e-05	0.000322	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1R—Parkinson's disease	6.74e-05	0.000321	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	6.74e-05	0.000321	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF2—Parkinson's disease	6.71e-05	0.00032	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF2—Parkinson's disease	6.71e-05	0.00032	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EDN1—Parkinson's disease	6.66e-05	0.000317	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—COMT—Parkinson's disease	6.66e-05	0.000317	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRBK1—Parkinson's disease	6.65e-05	0.000317	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTP1—Parkinson's disease	6.63e-05	0.000316	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MAOA—Parkinson's disease	6.62e-05	0.000315	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HMOX1—Parkinson's disease	6.54e-05	0.000312	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1R—Parkinson's disease	6.49e-05	0.000309	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1R—Parkinson's disease	6.49e-05	0.000309	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR7—Parkinson's disease	6.44e-05	0.000307	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD2—Parkinson's disease	6.44e-05	0.000307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EDN1—Parkinson's disease	6.41e-05	0.000306	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EDN1—Parkinson's disease	6.41e-05	0.000306	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—COMT—Parkinson's disease	6.4e-05	0.000305	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	6.37e-05	0.000303	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	6.35e-05	0.000303	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	6.31e-05	0.000301	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	6.28e-05	0.000299	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—Parkinson's disease	6.28e-05	0.000299	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—Parkinson's disease	6.27e-05	0.000299	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NGF—Parkinson's disease	6.12e-05	0.000292	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF2—Parkinson's disease	6.1e-05	0.00029	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTM1—Parkinson's disease	6.09e-05	0.00029	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	5.91e-05	0.000282	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NGF—Parkinson's disease	5.89e-05	0.000281	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1R—Parkinson's disease	5.89e-05	0.000281	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NGF—Parkinson's disease	5.89e-05	0.000281	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	5.85e-05	0.000279	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GPX1—Parkinson's disease	5.84e-05	0.000278	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—APOE—Parkinson's disease	5.84e-05	0.000278	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	5.83e-05	0.000278	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR2A—Parkinson's disease	5.83e-05	0.000278	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EDN1—Parkinson's disease	5.82e-05	0.000277	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—INS—Parkinson's disease	5.78e-05	0.000275	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	5.77e-05	0.000275	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR2A—Parkinson's disease	5.61e-05	0.000267	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR2A—Parkinson's disease	5.61e-05	0.000267	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.55e-05	0.000264	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	5.48e-05	0.000261	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APOE—Parkinson's disease	5.42e-05	0.000258	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.4e-05	0.000257	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF2—Parkinson's disease	5.4e-05	0.000257	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—Parkinson's disease	5.39e-05	0.000257	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NGF—Parkinson's disease	5.35e-05	0.000255	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	5.27e-05	0.000251	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1R—Parkinson's disease	5.22e-05	0.000249	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APOE—Parkinson's disease	5.22e-05	0.000249	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APOE—Parkinson's disease	5.22e-05	0.000249	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EDN1—Parkinson's disease	5.16e-05	0.000246	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR2A—Parkinson's disease	5.1e-05	0.000243	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—APOE—Parkinson's disease	5.01e-05	0.000239	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—INS—Parkinson's disease	4.99e-05	0.000238	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NGF—Parkinson's disease	4.74e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APOE—Parkinson's disease	4.74e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—INS—Parkinson's disease	4.63e-05	0.000221	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—COMT—Parkinson's disease	4.54e-05	0.000216	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	4.52e-05	0.000215	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR2A—Parkinson's disease	4.51e-05	0.000215	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	4.51e-05	0.000215	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	4.48e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—INS—Parkinson's disease	4.46e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—INS—Parkinson's disease	4.46e-05	0.000212	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	4.46e-05	0.000212	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—INS—Parkinson's disease	4.28e-05	0.000204	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOE—Parkinson's disease	4.19e-05	0.0002	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	4.15e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MCCC1—Parkinson's disease	4.15e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ND3—Parkinson's disease	4.15e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.09e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—INS—Parkinson's disease	4.05e-05	0.000193	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	3.92e-05	0.000187	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TALDO1—Parkinson's disease	3.9e-05	0.000186	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—OMD—Parkinson's disease	3.9e-05	0.000186	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.86e-05	0.000184	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	3.7e-05	0.000176	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—INS—Parkinson's disease	3.58e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	3.58e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.53e-05	0.000168	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCH1—Parkinson's disease	3.53e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—Parkinson's disease	3.45e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—Parkinson's disease	3.42e-05	0.000163	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—Parkinson's disease	3.32e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—Parkinson's disease	3.32e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—Parkinson's disease	3.3e-05	0.000157	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—Parkinson's disease	3.3e-05	0.000157	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK8—Parkinson's disease	3.17e-05	0.000151	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DBH—Parkinson's disease	3.14e-05	0.00015	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FBP1—Parkinson's disease	3.14e-05	0.00015	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GBA—Parkinson's disease	3.14e-05	0.00015	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK8—Parkinson's disease	3.05e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK8—Parkinson's disease	3.05e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—Parkinson's disease	3.01e-05	0.000144	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—Parkinson's disease	2.99e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.97e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.95e-05	0.000141	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.95e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ND3—Parkinson's disease	2.94e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.94e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.93e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.91e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK8—Parkinson's disease	2.77e-05	0.000132	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—OMD—Parkinson's disease	2.77e-05	0.000132	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.77e-05	0.000132	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.71e-05	0.000129	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.68e-05	0.000128	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—Parkinson's disease	2.67e-05	0.000127	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.62e-05	0.000125	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.5e-05	0.000119	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK8—Parkinson's disease	2.45e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DDC—Parkinson's disease	2.31e-05	0.00011	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GBA—Parkinson's disease	2.23e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DBH—Parkinson's disease	2.23e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.23e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.18e-05	0.000104	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—Parkinson's disease	2.02e-05	9.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.96e-05	9.35e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—Parkinson's disease	1.95e-05	9.28e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—Parkinson's disease	1.95e-05	9.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.94e-05	9.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ND3—Parkinson's disease	1.92e-05	9.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.92e-05	9.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—OMD—Parkinson's disease	1.81e-05	8.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.81e-05	8.62e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—Parkinson's disease	1.77e-05	8.42e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.72e-05	8.17e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DDC—Parkinson's disease	1.64e-05	7.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.64e-05	7.8e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—Parkinson's disease	1.57e-05	7.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.55e-05	7.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DBH—Parkinson's disease	1.46e-05	6.95e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.46e-05	6.95e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GBA—Parkinson's disease	1.46e-05	6.95e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.44e-05	6.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.42e-05	6.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.39e-05	6.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.38e-05	6.57e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.31e-05	6.22e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TH—Parkinson's disease	1.29e-05	6.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.24e-05	5.88e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COMT—Parkinson's disease	1.09e-05	5.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.09e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.09e-05	5.17e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.07e-05	5.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DDC—Parkinson's disease	1.07e-05	5.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.03e-05	4.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.01e-05	4.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.01e-05	4.79e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1e-05	4.77e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—Parkinson's disease	9.58e-06	4.56e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	9.37e-06	4.46e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NQO1—Parkinson's disease	9.26e-06	4.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TH—Parkinson's disease	9.13e-06	4.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.1e-06	4.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.01e-06	4.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—Parkinson's disease	8.84e-06	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYCS—Parkinson's disease	8.76e-06	4.18e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—Parkinson's disease	8.23e-06	3.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COMT—Parkinson's disease	7.76e-06	3.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.73e-06	3.68e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.71e-06	3.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.62e-06	3.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—Parkinson's disease	7.31e-06	3.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—Parkinson's disease	7.1e-06	3.38e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—INS—Parkinson's disease	7.03e-06	3.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.8e-06	3.24e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.7e-06	3.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.57e-06	3.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—Parkinson's disease	6.27e-06	2.99e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.12e-06	2.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.06e-06	2.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TH—Parkinson's disease	5.97e-06	2.84e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—Parkinson's disease	5.84e-06	2.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.73e-06	2.73e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COMT—Parkinson's disease	5.07e-06	2.42e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.05e-06	2.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.04e-06	2.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—INS—Parkinson's disease	4.99e-06	2.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.98e-06	2.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.78e-06	2.28e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.64e-06	2.21e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.44e-06	2.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.1e-06	1.95e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—Parkinson's disease	3.82e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—INS—Parkinson's disease	3.26e-06	1.55e-05	CbGpPWpGaD
